acea 1011 has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keana, JF; Lutfy, K; Weber, E; Woodward, RM | 1 |
| Guastella, J; Huettner, JE; Keana, JF; Tran, M; Weber, E; Woodward, RM | 1 |
2 other study(ies) available for acea 1011 and Seizures
| Article | Year |
|---|---|
Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011.
Topics: Analgesics; Animals; Dizocilpine Maleate; Dose-Response Relationship, Drug; In Vitro Techniques; Injections, Intraperitoneal; Injections, Spinal; Male; Mice; Morphine; Motor Activity; Oocytes; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Seizures; Xenopus laevis | 1994 |
Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systemically active ionotropic glutamate receptor antagonist.
Topics: Analgesics; Animals; Anticonvulsants; Brain; Cells, Cultured; Cloning, Molecular; Excitatory Amino Acid Antagonists; Mice; Neurons; Quinoxalines; Rats; Receptors, Glutamate; RNA, Messenger; Seizures; Xenopus laevis | 1995 |